drugset / Trial / NCT03496389

Does Gabapentin Reduce Quadriceps Muscle Weakness After Anterior Cruciate Ligament Reconstruction?

NCT03496389

Phase 2/3 Unknown 30 enrolled Hospital Authority, Hong Kong
RandomizedSingle-groupQuadruple-blindTreatment

Summary

Anterior cruciate ligament (ACL) injury is a common sport injury in both professional and recreational athletes. Furthermore, persistent quadriceps weakness and wasting are frequently observed after anterior cruciate ligament reconstruction (ACLR). Several studies have demonstrated that muscular rehabilitation to normal strength is difficult, protracted, and often not achieved due to the inability to fully activate the quadriceps voluntarily. Pain and disuse are often blamed for the inhibition of muscle activation following joint injury. However, arthrogenic muscle inhibition (AMI) is often overlooked and not addressed. Thus, the magnitude of strength restoration of the quadriceps is frequently restricted despite solid rehabilitation protocols. As AMI is a reflex inhibition of musculature involving the neurotransmitter γ-aminobutyrate (GABA), Gabapentin may have a potential role in modulating AMI, therefore limiting muscle weakness after ACLR.

Timeline

Start
2018-07-01
Primary completion
2019-07-01
Completion
2019-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg
Comparator Tramadol Other / unclassified 50 mg
Background Acetaminophen Small molecule 500 mg

Indications

No indication recorded.